Meeder Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
AIM
NAMA
Meeder Asset Management's EDIT Position: Q4 2021 in Review
Meeder Asset Management sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 3,143 shares — an estimated $129K sold.
Meeder Asset Management first reported a position in EDIT in Q4 2016 and held it in 15 quarters. The position peaked at $170K in Q3 2020. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.
- Meeder Asset Management reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
- Meeder Asset Management sold 3,143 Editas Medicine shares in Q4 2021, an estimated $129K.
- Meeder Asset Management first reported a position in Editas Medicine in Q4 2016 and held it in 15 quarters.
- Meeder Asset Management's Editas Medicine position peaked at $170K in Q3 2020.
- 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.
Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.